| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4763374
Max Phase: Preclinical
Molecular Formula: C21H16ClFN4O
Molecular Weight: 394.84
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: Oc1ccccc1CNc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1
Standard InChI: InChI=1S/C21H16ClFN4O/c22-17-10-15(5-7-18(17)23)27-21-16-9-14(6-8-19(16)25-12-26-21)24-11-13-3-1-2-4-20(13)28/h1-10,12,24,28H,11H2,(H,25,26,27)
Standard InChI Key: XFGBZNGMAMVEBG-UHFFFAOYSA-N
Associated Targets(non-human)
Middle East respiratory syndrome-related coronavirus 220 Activities
Vero 26788 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 394.84 | Molecular Weight (Monoisotopic): 394.0997 | AlogP: 5.48 | #Rotatable Bonds: 5 |
| Polar Surface Area: 70.07 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
| #RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 9.23 | CX Basic pKa: 4.53 | CX LogP: 5.10 | CX LogD: 5.09 |
| Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.42 | Np Likeness Score: -1.53 |
References
| 1. Lee JY,Shin YS,Lee J,Kwon S,Jin YH,Jang MS,Kim S,Song JH,Kim HR,Park CM. (2020) Identification of 4-anilino-6-aminoquinazoline derivatives as potential MERS-CoV inhibitors., 30 (20.0): [PMID:32781216] [10.1016/j.bmcl.2020.127472] |
Source
Source(1):